Market Research Logo

Cancer Genetics Inc (CGIX) - Product Pipeline Analysis, 2016 Update

Summary

Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH Microarrays, Next-Generation Sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic information to healthcare professionals, biopharma companies, and cancer centers. CGI’s clinical services include expand DX, test menu, complete program, and summation report. The company offers a range of pharmacogenomics testing services for clinical oncologists, cancer centers, and research institutions, and for biotech and biopharma customers engaged in clinical trials. It works in research collaboration with cancer centers to develop and validate proprietary tests. CGI is headquartered in Rutherford, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Cancer Genetics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Cancer Genetics Inc Company Overview
Cancer Genetics Inc Company Snapshot
Cancer Genetics Inc Pipeline Products and Clinical Trials Overview
Cancer Genetics Inc – Pipeline Analysis Overview
Key Facts
Cancer Genetics Inc - Major Products and Services
Cancer Genetics Inc Pipeline Products by Development Stage
Cancer Genetics Inc Pipeline Products Overview
Diagnostic Panel - Myelodysplastic Syndrome
Diagnostic Panel - Myelodysplastic Syndrome Product Overview
FHACT Test - Head and Neck Cancer
FHACT Test - Head and Neck Cancer Product Overview
FReCaD Renal Cancer Test
FReCaD Renal Cancer Test Product Overview
LeukA - Leukemia
LeukA - Leukemia Product Overview
MatBA Diagnostic Test - Marginal Zone Lymphoma
MatBA Diagnostic Test - Marginal Zone Lymphoma Product Overview
MatBA Diagnostic Test - Multiple Myeloma
MatBA Diagnostic Test - Multiple Myeloma Product Overview
Next-Gen DNA Sequencing Assay - Follicular Lymphoma
Next-Gen DNA Sequencing Assay - Follicular Lymphoma Product Overview
Next-Generation Sequencing Based Test - Lung Cancer
Next-Generation Sequencing Based Test - Lung Cancer Product Overview
UGenRA - Cervix
UGenRA - Cervix Product Overview
UGenRA - Endometrium
UGenRA - Endometrium Product Overview
UGenRA - Ovarian Cancer
UGenRA - Ovarian Cancer Product Overview
UroGenRA - Bladder
UroGenRA - Bladder Product Overview
UroGenRA - Prostate
UroGenRA - Prostate Product Overview
Cancer Genetics Inc - Key Competitors
Cancer Genetics Inc - Key Employees
Cancer Genetics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Cancer Genetics Inc, Recent Developments
Dec 01, 2016: Cancer Genetics and Leading Collaborators to Present Innovative Insights That Will Advance Precision Medicine in Diffuse Large B-cell Lymphoma (DLBCL) at American Society of Hematology (ASH) Annual Meeting 2016
Nov 10, 2016: Cancer Genetics Announces Strong Third Quarter with 68% Year over Year Revenue Growth and Highlights Path to Future Profitability
Nov 10, 2016: Sirona Dx Expands Next Generation Sequencing Services to Include Oncomine Focus Assay for Pharmaceutical Clients
Nov 02, 2016: Cancer Genetics Launches Focus::Renal, a Unique, Comprehensive and Highly Sensitive Next Generation Sequencing (NGS) Panel for Enabling Precision and Personalized Medicine in Renal Cancers
Aug 17, 2016: Cancer Genetics Strengthens Position as a Leader in Myeloid Cancer Diagnosis and Management Receiving New York State Approval for Focus::Myeloid, a Targeted NGS Panel for Improved Diagnosis, Risk Stratification, and Therapy Selection of Patients with
Aug 09, 2016: Cancer Genetics Reports Second Quarter 2016 Financial Results and Provides Company Updates
Jun 30, 2016: Cancer Genetics, Inc. Receives New York State Approval for Focus::CLL, a Unique NGS Panel for Chronic Lymphocytic Leukemia, Reinforcing CGI’s Market-Leading Position in the Diagnosis and Management of B-Cell Cancers
Jun 27, 2016: Cancer Genetics Names Healthcare Technology Industry Veteran John Jay Roberts as COO and Executive Vice President of Finance
Jun 02, 2016: Cancer Genetics Partners with ArcherDX to Offer Archer NGS Assays as a Sequencing Service for Biotech and Pharma
May 17, 2016: Cancer Genetics Launches The Most Comprehensive & Clinically Actionable Next Generation Sequencing Panel in Precision Medicine, FOCUS::Lymphoma
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Cancer Genetics Inc Pipeline Products and Clinical Trials Overview
Cancer Genetics Inc Pipeline Products by Equipment Type
Cancer Genetics Inc Pipeline Products by Indication
Cancer Genetics Inc, Key Facts
Cancer Genetics Inc, Major Products and Services
Cancer Genetics Inc Number of Pipeline Products by Development Stage
Cancer Genetics Inc Pipeline Products Summary by Development Stage
Diagnostic Panel - Myelodysplastic Syndrome - Product Status
Diagnostic Panel - Myelodysplastic Syndrome - Product Description
FHACT Test - Head and Neck Cancer - Product Status
FHACT Test - Head and Neck Cancer - Product Description
FReCaD Renal Cancer Test - Product Status
FReCaD Renal Cancer Test - Product Description
LeukA - Leukemia - Product Status
LeukA - Leukemia - Product Description
MatBA Diagnostic Test - Marginal Zone Lymphoma - Product Status
MatBA Diagnostic Test - Marginal Zone Lymphoma - Product Description
MatBA Diagnostic Test - Multiple Myeloma - Product Status
MatBA Diagnostic Test - Multiple Myeloma - Product Description
Next-Gen DNA Sequencing Assay - Follicular Lymphoma - Product Status
Next-Gen DNA Sequencing Assay - Follicular Lymphoma - Product Description
Next-Generation Sequencing Based Test - Lung Cancer - Product Status
Next-Generation Sequencing Based Test - Lung Cancer - Product Description
UGenRA - Cervix - Product Status
UGenRA - Cervix - Product Description
UGenRA - Endometrium - Product Status
UGenRA - Endometrium - Product Description
UGenRA - Ovarian Cancer - Product Status
UGenRA - Ovarian Cancer - Product Description
UroGenRA - Bladder - Product Status
UroGenRA - Bladder - Product Description
UroGenRA - Prostate - Product Status
UroGenRA - Prostate - Product Description
Cancer Genetics Inc, Key Employees
Table 7: Cancer Genetics Inc, Other Locations
Cancer Genetics Inc, Subsidiaries
List of Figures
Cancer Genetics Inc Pipeline Products by Equipment Type
Cancer Genetics Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report